These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20937191)

  • 1. Three phenotypes of obstructive lung disease in the elderly.
    Jo KW; Ra SW; Chae EJ; Seo JB; Kim NK; Lee JH; Kim EK; Lee YK; Kim TH; Huh JW; Kim WJ; Lee JH; Lee SM; Lim SY; Shin TR; Yoon HI; Sheen SS; Lee JS; Lee SD; Oh YM
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1481-8. PubMed ID: 20937191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosing obstructive lung disease. Why is differentiating COPD from asthma important?
    Subramanian D; Guntupalli KK
    Postgrad Med; 1994 Jun; 95(8):69-70, 75-8, 83-5. PubMed ID: 8202424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis of bronchial asthma and chronic obstructive lung disease by the family physician. Ad hoc consensus group 'Diagnosis of asthma/chronic obstructive lung disease by the family physician'].
    van Schayck CP
    Ned Tijdschr Geneeskd; 1995 Sep; 139(39):1966-71. PubMed ID: 7477538
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary study of the effects of postoperative methylprednisolone therapy on lung function recovery in patients with chronic obstructive pulmonary disease.
    Fraser IM; Hyland RH; Hutcheon MA; MacKenzie RL; Ameli FM; Provan JL
    Clin Pharm; 1989 Mar; 8(3):214-9. PubMed ID: 2706894
    [No Abstract]   [Full Text] [Related]  

  • 5. [Importance of spasm and way of reactivity to bronchodilatator of patients with chronic obstructive pulmonary disease (author's transl)].
    Sprung J
    Plucne Bolesti Tuberk; 1981; 33(1):8-13. PubMed ID: 7244024
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of spirometry on the management of chronic obstructive airway disease.
    Spann SJ
    J Fam Pract; 1983 Feb; 16(2):271-5. PubMed ID: 6822797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 56-year-old woman with mixed obstructive and restrictive lung disease.
    Khan SU; Kavuru MS
    Respir Care; 2000 May; 45(5):533-4. PubMed ID: 10813230
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of 16-week use of salmeterol on ECP levels, pulmonary function tests and bronchial hyperreactivity in patients with chronic obstructive lung disease].
    Chazan R; Jaworski A; Grubek-Jaworska H; Droszcz W
    Pol Tyg Lek; 1995 Oct; 50(40-44):48-9, 63. PubMed ID: 8650060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [When are bronchodilator agents sufficient in asthma/chronic obstructive pulmonary disease?].
    van Schayck CP; van Herwaarden CL; Folgering H; Akkermans R; van Weel C
    Ned Tijdschr Geneeskd; 1995 Aug; 139(31):1580-3. PubMed ID: 7675140
    [No Abstract]   [Full Text] [Related]  

  • 10. Predicting response to bronchodilator therapy in chronic obstructive pulmonary disease.
    Pratter MR; Irwin RS
    Arch Intern Med; 1988 Sep; 148(9):1909-10. PubMed ID: 3415402
    [No Abstract]   [Full Text] [Related]  

  • 11. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled glucocorticoids in chronic obstructive pulmonary disease.
    Mapp CE
    N Engl J Med; 2000 Dec; 343(26):1960-1. PubMed ID: 11136268
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of stable chronic obstructive lung disease with inhaled corticosteroid].
    Vestbo J; Lange P
    Ugeskr Laeger; 2000 Jan; 162(4):520-3. PubMed ID: 10697457
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative 15 steps exercise oximetry as a marker of disease severity in patients with chronic obstructive pulmonary disease.
    Kramer MR; Krivoruk V; Lebzelter J; Liani M; Fink G
    Isr Med Assoc J; 1999 Nov; 1(3):165-8. PubMed ID: 10731326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The hypersensitive bronchial system. Significance for prognosis inhibition of progression of chronic obstructive respiratory tract diseases].
    Nowak D; Magnussen H
    Internist (Berl); 1993 Apr; 34(4):294-9. PubMed ID: 8486472
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparing the bronchodilating effects of ipratropium bromide and theophylline].
    Dai L; Li X; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):609-11. PubMed ID: 11477880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FVC response in bronchoreversibility test.
    Chhabra SK
    Indian J Chest Dis Allied Sci; 2001; 43(1):9-11. PubMed ID: 11370510
    [No Abstract]   [Full Text] [Related]  

  • 18. Airflow limitation--reversible or irreversible.
    Lancet; 1988 Jan 2-9; 1(8575-6):26-7. PubMed ID: 2891892
    [No Abstract]   [Full Text] [Related]  

  • 19. [Greater decrease in lung function in COPD during continuous rather than during symptom-oriented bronchodilator medication].
    Geijer R
    Ned Tijdschr Geneeskd; 1993 Mar; 137(10):517. PubMed ID: 8455744
    [No Abstract]   [Full Text] [Related]  

  • 20. Categorisation of ventilatory pattern of response to bronchodilator therapy in airflow limitation.
    Meenakshi S
    J Assoc Physicians India; 1995 Mar; 43(3):179-81. PubMed ID: 11256903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.